{"id":"W2219463573","doi":"10.1016/s1470-2045(15)00554-9","title":"TIME for a successful cancer vaccine in NSCLC?","year":2015,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Docetaxel; Oncology; Lung cancer; Internal medicine; Clinical trial; Chemotherapy; Clinical endpoint; Cancer; Immunotherapy; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007262159,0.0008354162,0.002101818,0.000650976,0.00300366,0.004828008,0.001613081,0.05762976,0.01001294],"category_scores_gemma":[0.04086122,0.0007228504,0.001769806,0.0003683643,0.004026289,0.007505091,0.003349021,0.04372379,0.006944584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005125508,"about_ca_system_score_gemma":0.005423367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002736365,"about_ca_topic_score_gemma":0.005986047,"domain_scores_codex":[0.994635,0.002037816,0.000627087,0.0004896884,0.001368727,0.0008415799],"domain_scores_gemma":[0.9864751,0.008514474,0.001033688,0.0003830655,0.001199048,0.002394766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000168348,0.00006621359,0.0006004864,0.0001483532,0.00003472672,0.001035317,0.00009781058,0.0001489905,0.0003086566,0.008712373,0.9604088,0.02826995],"study_design_scores_gemma":[0.0003482889,0.0002493858,0.0006109679,0.0006131104,0.00006169789,0.00126284,0.0003383856,0.0004905699,0.0002960474,0.03208599,0.9635757,0.0000669225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001642285,0.003803453,0.00008189744,0.9830283,0.01180141,0.000004893896,0.0000264423,0.00001422742,0.001075284],"genre_scores_gemma":[0.003727378,0.002464749,0.0002032669,0.9496841,0.04079262,0.00002926525,0.00003212731,0.00001469657,0.003051722],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05762976,"threshold_uncertainty_score":0.03840643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05510566192699651,"score_gpt":0.3677829949587555,"score_spread":0.312677333031759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}